AC Immune
-$0.04 (-1.23%) Today
+$0.04 (+1.24%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.
About ACIU
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
CEO
Andrea Pfeifer
Employees
143
Headquarters
Lausanne, Vaud
Founded
2003
ACIU Key Statistics
Market cap
269.04M
Price-Earnings ratio
—
Dividend yield
—
Average volume
133.82K
High today
$3.31
Low today
$3.17
Open price
$3.31
Volume
50.13K
52 Week high
$12.61
52 Week low
$2.46
ACIU Earnings
-$0.30
-$0.16
-$0.03
$0.11
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market